TruthArchive.ai - Related Video Feed

The speaker discusses the safety of the COVID vaccine, specifically focusing on Pfizer's safety trials. They highlight that the trials were short and had a 1 in 800 rate of serious adverse events per shot. They express concern about the long-term effects and mention a potential estimate of 17 million deaths globally from the vaccine. The speaker acknowledges the magnitude of this number, comparing it to the death toll of a global war.

In the video, the speaker asks about grade 4 events and deaths reported in the trials. The doctor explains that there were a total of 14 fatal events, with 10 occurring in nasefimab recipients and 4 in placebo recipients. However, the deaths were balanced between the groups due to the randomization. None of the deaths were related to the product, and the causes were in line with the general population's mortality rates. The speaker then asks about grade 4 adverse events, but the doctor is unable to respond immediately without reviewing the data. They request follow-up via written response or at another time. The speaker emphasizes the importance of safety.

The CDC triggered a comprehensive review of all databases after seeing a signal in one small database regarding potential safety issues with the booster. However, no safety concerns were found in the review of all databases in existence. The speaker mentioned that their own investigation in Europe, Israel, and the US also found no safety issues. They have a team collaborating with scientific institutions to constantly review and analyze data, and no signals of safety concerns have been found.

The speaker wants to raise awareness about what happened to Alexis, hoping it will aid medical professionals and those helping Todd and his family. The speaker states that administering three shots simultaneously in a hospital involves tetanus, meningitis, and pneumonia vaccines. The speaker claims that medical doctors at the hospital are unaware that there are 19 different brand-name tetanus, meningitis, and pneumonia shots listed on the CDC's vaccine excipient summary. The speaker asserts that Alexis's symptoms are identical to those caused by three known published poisons found within those 19 vaccines, of which Alexis received three.

Speaker 0 is pleased about vaccination effectiveness in preventing severe COVID and long-term effects. They mention rare side effects from vaccines and emphasize the importance of ongoing monitoring. Speaker 1 questions the safety of products on the market without complete testing. The TGA lacks data on adverse events due to underreporting, leading to audience frustration.

The discussion centers on concerns about the safety of pediatric vaccines, the governing framework for vaccination and related notifications, and how schools and child-care settings handle cases where vaccination is incomplete. Key points raised by Speaker 0 (in Japanese) include: - The number and variety of pediatric vaccines have been increasing, with regular schedules reaching up to about 30 doses from birth. - Some vaccines include additives such as thiomersal (mercury-containing) and, in the case of influenza vaccines given after six months, thiomersal and aluminum compounds, causing anxiety about brain development and cancer risk. - Thiomersal is described as an organomercury compound that biodegrades to ethylmercury; its linkage to neurodevelopmental disorders has been asserted in materials from the Ministry of Health, Labour and Welfare (MHLW). The materials indicate thiomersal and other additives (e.g., aluminum compounds) can be associated with concerns about cancer risk and memory impairment. The presenter cites materials labeled as current vaccine formulations like “Beugen” (B型肝炎ワクチン) containing thiomersal and organic silver derivatives, and notes concerns about aluminum compounds. - The speaker emphasizes that even with explanations from experts that trace amounts are unlikely to have measurable effects, caregivers remain cautious, influencing decisions about vaccinating their children. - There is a claim that disease risk reduction and broader environmental exposure concerns (e.g., artificial sweeteners, nicotine residues, colorants) contribute to vaccine hesitancy, especially given declining birth rates yet rising incidences of developmental disorders, dementia, or behavior-related conditions. - The speaker asks for the audience’s attention to the confusion surrounding vaccines and their additives, seeking to understand why some guardians opt not to vaccinate. Key organizational questions and clarifications provided by Speaker 1: - Under the Public Health Vaccination Act, local governments issue vaccination recommendations and encourage vaccination, including sending vaccination advisories that specify the timing and method. The notices concern vaccines such as the measles-mumps-rubella (MMR), human papillomavirus (HPV), and Japanese encephalitis vaccines. The advisory notices are not mandatory, but vaccination is strongly encouraged. - When a guardian declines vaccination, it does not constitute abuse or neglect according to the law; preventive services and enforcement do not classify non-vaccination as neglect. Speaker 3 and Speaker 4 address practical and ethical concerns in child-care and education contexts: - In child-care facilities, there is no legal right to label a guardian as neglect simply for non-vaccination, though vaccination status is recorded in health forms. They stress the goal of preventing punitive treatment of guardians and promoting fair, informed medical care for children. - Questions are raised about whether vaccination histories influence admission or screening processes for child-care and school enrollment. The response indicates vaccination status is not a disqualifying factor for admission, and the health information form includes vaccination history; non-vaccinated children should not be disadvantaged in enrollment. - It is acknowledged that some guardians and teachers may hold misconceptions about vaccines, including concerns about toxins. The discussion calls for improved information sharing among health services, childcare, and education officials to reduce misinformation and support informed decisions. Speaker 2 (Takena Kazuko, Head of Childcare Family Division) and Speaker 4 (Ministry or Education official) respond to concerns about information sharing and the role of staff training: - They emphasize the distinction between compulsory vaccination guidance and voluntary advisories, reiterating that withholding vaccination is not automatically considered neglect. - They agree on the need to prevent punitive attitudes toward guardians, to inform teachers and childcare staff about how to communicate vaccine information, and to ensure consistent understanding across health, childcare, and education sectors. - A request is made to improve public awareness so that vaccination decisions are respected and differences in opinion are honored. Overall, the transcript details regulatory mechanisms for vaccination recommendations, the non-punitive stance toward non-vaccination in guardians, and the need for better information sharing and respectful dialogue among public health, childcare providers, and schools to address vaccine hesitancy without resorting to neglect determinations.

The discussion revolves around the lack of complete safety study information in the patient package insert for the Moderna vaccine. The speaker acknowledges the missing data but assures safety based on personal experience. When asked about the specific studies supporting the vaccine's safety and effectiveness, the speaker admits to not having an answer. The conversation ends with the speaker feeling inadequate for not being able to provide more information.

They discuss the number of people who have experienced long-term health issues after receiving the vaccine. The speaker asks if it's hundreds or thousands, and Helen responds that it's actually around 10. She mentions a report from April 2023, which states that there were 11,289 medically significant or serious reports. Out of those, 1,062 were listed as disabled, 118 were considered life-threatening, and 184 resulted in death. Helen clarifies that the long-term consequences are not in the hundreds or thousands, but rather around 10.

The speaker discusses a paper from Denmark that reveals a significant variation in suspected adverse reactions to the Pfizer vaccine. The data shows a 1,000-fold difference in incidence depending on the batch of vaccines administered. This information is currently gaining popularity.

The speaker discusses the safety data of Pfizer's vaccine trials, highlighting the short duration of the trials and the potential for serious adverse events. They mention a 1 in 800 rate of serious harm per shot and express concern about the long-term effects and mortality risk. They mention an estimate of 17 million global deaths from the vaccine and compare it to the death toll of a global war. The speaker emphasizes the seriousness of the situation.

The speaker argues that an irrational, unbridled enthusiasm for new possibilities leads to a sacrifice of safety. This enthusiasm, in their view, has adversely affected precautionary considerations and risk assessment. They reference presenting autopsy findings related to deaths following COVID-19 vaccination at the American Society of Microbiology, an event attended by thousands of microbiologists, vaccinologists, and immunologists. In conversations with attendees, the speaker was surprised by what they describe as a scientific seduction surrounding messenger RNA technology. The core concern expressed is that this eagerness to embrace mRNA platforms is accompanied by a neglect of safety considerations. The speaker asserts that there will be a cataclysmic recognition that messenger RNA technology represents an unsafe platform. They emphasize that, as they understand it, there is no way to break down certain aspects of the technology they refer to as “pseudourogenated messenger RNA,” noting this within the context of their work in research laboratories. The statement implies a belief that the degradation or metabolic processing of this form of RNA poses unresolved issues. A central, striking claim presented is that circulating messenger RNA from Pfizer or Moderna has been found in their patients’ bloodstream three years after vaccination, and that this RNA is intact. The speaker underscores this as evidence tied to their observations and research experiences, asserting the persistence of the RNA in the circulatory system over an extended period. Overall, the message conveys a perspective that rapid adoption and optimism around mRNA vaccines and technologies have overshadowed safety considerations, and it anticipates a future realization of safety concerns associated with these platforms. The speaker ties their warnings to concrete experiences at a major scientific conference and to specific, long-term biomarkers observed in patients, presenting a narrative of ongoing research findings and anticipated paradigm shifts in how the safety of mRNA vaccines is perceived.

I am one of the scientists involved in a study on the safety and dependency of vaccine batches. We found three types of side effects: mild, severe, and even death. These adverse effects were present in the initial batches, which may have been changed during production or transportation. Patients were not informed of the risks and some received poor-quality batches. The Vice President of Pfizer admitted to building the plane while flying, and we have shown that one wing has fallen off. There is a safety issue that the European Medicines Agency (EMA) and national institutions should have addressed and informed the public about. Our study also suggests a potential link between certain cancers and different vaccine batches. We have observed increased mortality rates in European countries since May 21st. The EMA should have reacted to these findings and halted vaccinations or at least withdrawn the problematic batches. As a concerned citizen and doctor, I expected more action from the EMA. Thank you.

The speaker discusses the severe damage caused by multiple doses of a certain substance, suggesting that taking it once is enough. They mention leaked documents from Pfizer and Moderna, revealing different lot numbers and formulations. The FDA's role is to ensure uniformity and safety across the country, but the speaker claims that different concentrations and ingredients were used, resulting in varying effects. Some lots were found to be 5000% more lethal than others. The speaker suggests that this variation was intentional to prevent clear correlation and discourage people from realizing they were being poisoned.

The speaker states they searched for years for a pre-licensing safety trial of the 72 vaccine doses effectively mandated for American children. They claim that every other medication requires a safety trial comparing health outcomes in a placebo group versus a vaccine group before FDA licensing. The speaker assumed this was also done for vaccines. They state they found out that vaccines were exempt from this requirement.

Speaker 0 asks Speaker 1 to explain why the vaccine causes myocarditis and pericarditis. Speaker 1 mentions rare reports of myocarditis and pericarditis associated with vaccination but does not provide a clear explanation. Speaker 0 insists on understanding the mechanism and questions why the vaccine is considered safe without addressing the risks. Speaker 2 intervenes, suggesting that Speaker 1 will address the question later. Speaker 1 talks about the benefit-risk ratio and the global recommendation of health authorities. Speaker 0 reiterates the question, to which Speaker 1 agrees to provide a response later. Speaker 2 confirms this agreement.

The speakers express concern that only a small percentage of adverse reactions to vaccines are reported. Despite this, they assure viewers that the COVID vaccine is safe. They highlight that prior to the COVID vaccine rollout, an average of 1500 adverse event reports were received each year for all vaccines in New Zealand, resulting in one or fewer reported deaths annually.

The head of the vaccine program, Dr. Stanley Plotkin, discusses the need for more post-authorization vaccine safety studies. He acknowledges the lack of proper safety studies before licensing vaccines and calls for more research to understand adverse reactions. Plotkin emphasizes the importance of identifying biological mechanisms of adverse reactions to develop safer vaccines. He highlights the slow progress in vaccine safety science and the need for adequate funding to address public concerns about vaccine safety. Ultimately, he urges for more comprehensive safety studies to ensure the safety of vaccines.

Speaker 0 questions Speaker 1 about a report stating that serious adverse reactions occur in 1 in 800 vaccinated individuals. Speaker 1 claims to be unaware of the report but mentions routine screening of literature for adverse events. When asked about Moderna's rate of serious adverse events, Speaker 1 cannot provide the information. Speaker 0 expresses frustration and finds it extraordinary that a multinational company cannot provide this data. Speaker 1 offers to provide the information later but states that no safety concerns were observed in their clinical trials. Speaker 0 concludes that the conversation is a waste of time.

They received texts claiming extraordinary lives, but the speaker asks how many people have suffered long-term health consequences from the vaccine. The other person, Helen, responds that there have been 10 cases of long-term consequences. In March 2023, MedSafe received 11,289 reports, with 1,062 listed as disabled, 118 as life-threatening, and 184 as deaths. The speaker clarifies if it's 100 or 1,000 cases, but Helen confirms it's around 10 for long-term effects.

The speaker asked why the FDA and HHS removed thimerosal from most children's vaccines but left it in a few. They admitted not being vaccine experts and offered to investigate and provide more information later. The speaker expressed interest in sharing the answer with the public.

The speaker discusses the presence of DNA in the Pfizer vaccine and expresses concern about its potential consequences. They explain that they sequenced the DNA in the vaccine and found it surprising that any DNA was present. The speaker suggests that this DNA could be causing rare but serious side effects, such as death from cardiac arrest. They also mention that the DNA could integrate into the genomic DNA of cells, potentially leading to genome modification, autoimmune attacks, or even future cancer. The speaker acknowledges that these concerns are theoretical but believes they warrant further investigation.

The speaker asked about the long-term effects of the vaccine, but the response was unclear. The speaker mentioned that the effects at one year are known, but not at three to five years. They also mentioned that 93% of the population will be vaccinated. The speaker seemed unsure and mentioned feeling pressured at work.

Speaker 0 asks Speaker 1 to explain the process of how the vaccine causes myocarditis and pericarditis. Speaker 1 mentions rare reports of myocarditis and pericarditis associated with vaccination. Speaker 0 insists on an explanation of the mechanism, but Speaker 1 does not provide a direct answer. Speaker 1 emphasizes that all medicines have benefits and side effects and refers to the benefit-risk ratio. Speaker 0 continues to press for an explanation of the biochemical pathway, but Speaker 1 agrees to provide a response later. The transcript ends with Speaker 2 confirming Speaker 1's agreement to give a further response.

Are there concerns regarding the side effects of medicines? Is safety testing necessary? We are administering genetically modified organisms through injections, particularly in young children.

The speakers express concern about the limited reporting of adverse reactions to vaccines. They mention a report suggesting that only 5% of adverse reactions are recorded in the database. Despite this, they assure viewers that the COVID vaccine is safe. They highlight that prior to the COVID vaccine rollout, the average number of adverse event reports for all vaccines in New Zealand was 1500 per year, with one or fewer deaths reported annually.